Neutron Delayed Again—Buying Hope Isn’t a Retirement Strategy, Folks

Rocket Lab postponed the Neutron rocket’s inaugural launch. Again. And investors barely shrugged — the stock moved a couple of percent. Of course it did. At this stage, the Neutron delay is less a news event and more a scheduled calendar notification.

Let’s be honest about what’s happening here. Rocket Lab has been vague — deliberately, professionally vague — about when Neutron will actually fly. Vagueness in aerospace scheduling is a symptom, not a strategy. When a company can’t give you a date, it’s because it doesn’t have one, and when it doesn’t have one, it’s because the engineering isn’t done. That’s not cynicism; that’s how development programs work. Anyone pricing RKLB stock on the assumption of a specific launch window is doing religion, not analysis.

Here’s where the FIRE crowd should be paying attention, because the lesson generalizes far past one rocket company. Speculative growth stocks are lottery tickets with extra steps. You’re paying today for cash flows that may or may not materialize years from now, contingent on milestones the company keeps moving. Compare that to, say, an S&P 500 index fund charging 0.03% in expense ratios, historically compounding around 10% annually over long stretches. Every dollar parked in a pre-revenue moonshot is a dollar not compounding in the boring machine that actually builds wealth. Opportunity cost is the most ruthless accountant you’ll ever meet, and it never takes a vacation.

Now, to be fair — and being fair to Rocket Lab is genuinely annoying — the company does have real revenue from its Electron launch business and space systems segment. This isn’t a vaporware startup. Peter Beck’s team has executed before, and Electron flies regularly. The bull case isn’t insane. But there’s a canyon of difference between a company that executes on proven revenue and a valuation that depends on a reusable medium-lift rocket competing against SpaceX’s Falcon 9, which has already flown hundreds of missions and made reusability routine. Neutron isn’t entering a market. It’s entering a market SpaceX already owns, at price points SpaceX already set.

And notice who keeps promoting RKLB as the “next SpaceX.” It’s the same financial media complex that needs a hot story every week, the sameMotley-Fool-style content mills churning out tickers with percentage fluctuations attached, the same commentators who recommended every stock at its all-time high. Their incentive is your attention, not your returns. Ask yourself: when the “next SpaceX” narrative fails to materialize on schedule, who eats the drawdown? Not the pundit.

The arithmetic of waiting is brutal. If you bought RKLB at $15 hoping Neutron launches in 2025, and it slips to 2026, then 2027 — your capital has been dead weight the entire time, absorbing volatility while paying you nothing. Meanwhile, your index fund neighbor just let compounding do its one job. Speculation isn’t just risky; it’s slow, and slow is the one thing compounding can’t forgive.

Will Neutron eventually fly? Probably. Will it fly on any timeline management has communicated so far? The evidence suggests you should assume no. So the only rational question is what you’re paying today for that probability, and whether the answer survives contact with a spreadsheet.

Rocket companies run on thrust, but portfolios run on time. Rocket Lab is burning one; make sure you’re not burning yours.